Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2014; 139(S 04): S136-S141
DOI: 10.1055/s-0034-1387453
DOI: 10.1055/s-0034-1387453
Übersicht | Review article
Pneumologie
Allgemeine Therapie der pulmonal arteriellen Hypertonie
Supportive therapy in pulmonary arterial hypertensionFurther Information
Publication History
09 October 2014
23 October 2014
Publication Date:
09 December 2014 (online)
-
Literatur
- 1 Galiè N, Hoeper M, Humbert M et al. Guidelines on diagnosis and treatment of pulmonary hypertension: the Task Force on Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology and of the European Respiratory Society. Eur Heart J 2009; 30: 2493-537
- 2 Jais X, Olsson KM, Barbera JA et al. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J 2012; 40: 881-5
- 3 Mereles D, Ehlken N, Kreuscher S et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 2006; 114: 1482-9
- 4 Weinstein AA, Chin LMK, Keyser RE et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respir Med 2013; 107: 778-84
- 5 Chan L, Chin LM, Kennedy M et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest 2013; 143: 333-43
- 6 de Man FS, Handoko ML, Groepenhoff H et al. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2009; 34: 669-75
- 7 Grünig E, Ehlken N, Ghofrani A et al. Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration 2011; 81: 394-401
- 8 Becker-Grunig T, Klose H, Ehlken N et al. Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease. Int J Cardiol 2013; 168: 375-81
- 9 Grünig E, Maier F, Ehlken N et al. Exercise training in pulmonary arterial hypertension associated with connective tissue diseases. Arthritis Res Ther 2012; 14: R148
- 10 Nagel C, Prange F, Guth S et al. Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension. PLoS One 2012; 7 (07) e41603
- 11 Grünig E, Lichtblau M, Ehlken N et al. Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J 2012; 40: 84-92
- 12 Löwe B, Gräfe K, Ufer C et al. Anxiety and depression in patients with pulmonary hypertension. Psychosom Med 2004; 66 (06) 831-6
- 13 Halank M, Einsle F, Lehman S et al. Exercise capacity affects quality of life in patients with pulmonary hypertension. Lung 2013; 191 (04) 337-43
- 14 Harzheim D, Klose H, Pinado FP et al. Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Respir Res 2013; 14: 104
- 15 Whooley MA, Simon GE. Managing depression in medical outpatients. N Engl J Med 2000; 343 (26) 1942-50
- 16 Ladwig KH, Lederbogen F, Albus C et al. Position paper on the importance of psychosocial factors in cardiology: Update 2013. Ger Med Sci 2014; 12 Doc09
- 17 Burns RM, Peacock AJ, Johnson MK et al. Hypoxaemia in patients with pulmonary arterial hypertension during simulated air travel. Respir Med 2013; 107: 298-304
- 18 Price LC, Montani D, Jais X et al. Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension. Eur Respir J 2010; 35: 1294-1302
- 19 Ramakrishna G, Sprung J, Ravi BS et al. Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol 2005; 45: 1691-1699
- 20 Kaw R, Pasupuleti V, Deshpande A et al. Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery. Respir Med 2011; 105: 619-624
- 21 Meyer S, McLaughlin VV, Seyfarth HJ et al. Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. Eur Respir J 2013; 41 (06) 1302-7
- 22 Preckel B, Eberl S, Fräßdorf J et al. Management of patients with pulmonary hypertension. Anaesthesist 2012; 61 (07) 574-77, 580-7
- 23 Gille J, Seyfarth HJ, Gerlach S et al. Perioperative anesthesiological management of patients with pulmonary hypertension. Anesthesiol Res Pract 2012; 2012: 356982
- 24 Wiklund L, Haraldsson A, Selimovic N et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation in a patient with persistent severe porto-pulmonary arterial hypertension following liver transplantation. Eur J Cardiothorac Surg 2011; 39 (05) 777-8
- 25 Hoeper MM, Granton J. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med 2011; 184 (10) 1114-24
- 26 Abrams DC, Brodie D, Rosenzweig EB et al. Upper-body extracorporeal membrane oxygenation as a strategy in decompensated pulmonary arterial hypertension. Pulm Circ 2013; 3 (02) 432-5
- 27 Maron BA, Zhang YY, White K et al. Aldosterone Inactivates the Endothelin-B Receptor via a Cysteinyl Thiol Redox Switch to Decrease Pulmonary Nitric Oxide Levels and Modulate Pulmonary Arterial Hypertension. Circulation 2012; 126: 963-974
- 28 Maron BA, Opotowsky AR, Landzberg MJ et al. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study. Eur J Heart Fail 2013; 15: 277-283
- 29 de Man FS, Handoko ML, Guignabert C et al. Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?. Am J Respir Crit Care Med 2013; 187 (01) 14-9
- 30 Galiè N, Corris PA, Frost A et al. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol 2013; 62 (Suppl. 25) D60-72
- 31 Sandoval J, Aguirre JS, Pulido T et al. Nocturnal oxygen therapy in patients with the Eisenmenger syndrome. Am J Respir Crit Care Med 2001; 164: 1682-1687
- 32 Minai OA, Pandya CM, Golish JA et al. Predictors of nocturnal oxygen desaturation in pulmonary arterial hypertension. Chest 2007; 131: 109-117
- 33 Hildebrand FF, Bloch KE, Speich R et al. Daytime measurements underestimate nocturnal oxygen desaturations in pulmonary arterial and chronic thrombembolic pulmonary hypertension. Respiration 2012; 84: 477-484
- 34 Ulrich S, Keusch S, Hildenbrand FF et al. Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with pre-capillary pulmonary hypertension and sleep-disturbed breathing: randomized, double-blind, cross-over trial. Eur Heart J 2013;
- 35 Olsson KM, Delcroix M, Ghofrani HA et al. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation 2014; 129 (01) 57-65
- 36 Tongers J, Schwerdtfeger B, Klein G et al. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 2007; 153: 127-132
- 37 Olsson KM, Nickel NP, Tongers J et al. Atrial flutter and fibrillation in patients with pulmonary hypertension. Int J Cardiol 2013; 167: 2300-2305
- 38 Hoeper MM, Galie N, Murali S et al. Outcome after cardiopulmonary resucitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 2002; 165: 341-344
- 39 Luesebrink U, Fischer D, Gezgin F et al. Ablation of typical right atrial flutter in patients with pulmonary hypertension. Heart Lung and Circ 2012; 21: 695-699
- 40 Ghofrani HA, Dislter O, Gerhardt F et al. Therapie der pulmonalen arteriellen Hypertonie (PAH). Empfehlungen der Kölner Konsensus Konferenz 2010. Dtsch Med Wochenschr 2010; 135: S87-S101
- 41 Rabinovitz A, Raiszadeh F, Zolty R. Association of Hyponatremia and Outcomes in Pulmonary Hypertension. J Cardiac Fail 2013; 19: 550-556
- 42 De Man FS, Tu L, Handoko ML et al. Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med 2012; 186: 780-790
- 43 Ruiter G, Lankhorst S, Boonstra A et al. Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J 2011; 37: 1386-91
- 44 Viethen T, Gerhardt F, Dumitrescu D et al. Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: a pilot study. Int J Cardiol 2014; 175 (02) 233-9
- 45 Wozencraft CP, Coyne PJ, Grinnan DC et al. Epoprostenol use for pulmonary arterial hypertension in the palliative care setting. J Palliat Med 2012; 15 (05) 619-22
- 46 Gamborg H, Riis J, Christrup L et al. Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases. J Opioid Manag 2013; 9 (04) 269-74
- 47 Rocker GM, Simpson AC, Young J et al. Opioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: patients' experiences and outcomes. CMAJ Open 2013; 1 (01) E27-36
- 48 Thiemann DR, Coresh J, Oetgen WJ et al. The association between hospital volume and survival after acute myocardial infarction in elderly patients. N Engl J Med 1999; 340: 1640-8
- 49 Delcroix M, Naeije R. Optimising the management of pulmonary arterial hypertension patients: emergency treatments. Eur Respir Rev 2010; 19: 204-11
- 50 Delcroix M, Adir Y, Andreassen AK et al. Care organization for pulmonary arterial hypertension in developed countries: a survey. J Heart Lung Transplant 2012; 31 (Suppl. 04) s81-2
- 51 Larisch A, Neeb C, de Zwaan M, Pabst C, Tiede H, Ghofrani A, Olsson K, Hoeper M, Kruse J. Mental distress and wish for psychosomatic treatment of patients with pulmonary hypertension. Psychother Psychosom Med Psychol 2014; 64: 384-389